---
title: "Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Showcases Unique MS Drug Candidate, Growth Strategy During Executive Podcast"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291450355.md"
description: "Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Showcases Unique MS Drug Candidate, Growth Strategy During Executive Podcast"
datetime: "2026-07-01T18:15:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291450355.md)
  - [en](https://longbridge.com/en/news/291450355.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291450355.md)
generator: "portal-rs"
---

# Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Showcases Unique MS Drug Candidate, Growth Strategy During Executive Podcast


### Related Stocks

- [QNTM.US](https://longbridge.com/en/quote/QNTM.US.md)

## Related News & Research

- [Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Lower Q2 Expenses, Advances Lucid-MS Into Phase 2](https://longbridge.com/en/news/296129489.md)
- [Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Myelin-Protecting MS Therapy as Treatment Paradigm Evolves](https://longbridge.com/en/news/296514765.md)
- [MoneyMasters Podcast: S&P 500 Vs. TSX – Which Leads Next?](https://longbridge.com/en/news/295823219.md)
- [Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Targets Disability Drivers Beyond Relapse Rates in Multiple Sclerosis](https://longbridge.com/en/news/295819977.md)
- [Triton Digital Q2 2026 podcast ranker shows News reach rises 8.4% ahead of US midterms](https://longbridge.com/en/news/296470379.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**